Lonza predicts growth despite strong Swiss franc in 2015
Lonza has predicted that revenues and profits will grow in 2015 despite the strong franc, citing pharma portfolio optimization and demand for outsourced manufacturing services.
Lonza has predicted that revenues and profits will grow in 2015 despite the strong franc, citing pharma portfolio optimization and demand for outsourced manufacturing services.
Japan’s membership of the PIC/S international inspection and manufacturing scheme bodes well for patients in Japan and elsewhere according to the Ministry of Health, Labour and Welfare and Pharmaceuticals and Medical Devices Agency (MHLW)
Biotech giant Amgen has begun hiring about 100 more research scientists and production engineers as part of an expansion at its office in Cambridge, Massachusetts at the same time as laying off more than 2,000 employees at other sites.
EBG BIOSIMILARS 2015
Sponsors can license biosimilars for multiple indications without performing clinical studies for each area, the EMA and FDA agree.